Overview

Evaluation of Oral THC and CBD in Men and Women

Status:
Not yet recruiting

Trial end date:
2024-11-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine the pharmacokinetics and pharmacodynamics of oral delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) and to evaluate detection of recently smoked THC in oral fluid.

Phase:

Phase 1

Details

Lead Sponsor:

University of California, Los Angeles

Treatments:

Dronabinol